Skip to main content
Health & Medicine

Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial.

| Source: Nature medicine

Allogeneic hematopoietic cell transplantation can cure certain hematological disorders but has many complications. In retrospective studies, low gut microbiome diversity is associated with adverse clinical outcomes. In 2023, the Blood and Marrow Transplant Clinical Trials Network 1703 randomized phase 3 trial demonstrated the superiority of post-transplant cyclophosphamide (PTCy) and mycophenolate mofetil to tacrolimus and methotrexate (Tac/MTX) for graft-versus-host disease prophylaxis in parti

Allogeneic hematopoietic cell transplantation can cure certain hematological disorders but has many complications. In retrospective studies, low gut microbiome diversity is associated with adverse clinical outcomes. In 2023, the Blood and Marrow Transplant Clinical Trials Network 1703 randomized phase 3 trial demonstrated the superiority of post-transplant cyclophosphamide (PTCy) and mycophenolate mofetil to tacrolimus and methotrexate (Tac/MTX) for graft-versus-host disease prophylaxis in participants with hematological malignancies undergoing allogeneic hematopoietic cell transplantation. Here we report on the microbiome-focused companion study to 1703, Blood and Marrow Transplant Clinical Trials Network 1801, which coenrolled participants and shared trial registration. The primary endpoint was association between microbiome diversity at neutrophil engraftment and non-relapse mortality after 1 year; secondary endpoints included associations with other clinical outcomes and with baseline microbiome diversity. Based on 2575 longitudinally collected stool samples from 304 participants (Tac/MTX n = 147, PTCy n = 157), no association between engraftment microbiome diversity and non-relapse mortality was observed (P = 0.314), not meeting the primary endpoint. Lower baseline microbiome diversity was associated with shorter overall survival (P = 0.007). Safety data were reported in the original 1703 publication. In exploratory analyses, microbiome diversity and absolute microbial load were lower in PTCy compared to Tac/MTX on days 14-28 following HCT, independent of non-prophylaxis antibiotics exposure. Microbial domination events, when a single species exceeds 30% relative abundance, did not differ significantly between study arms and reflected both pathogen blooms and less severe disruptions of the microbial community. Clostridium scindens and secondary bile-acid metabolism pathways were less prevalent in PTCy than in Tac/MTX following HCT. In summary, we find prophylaxis regimens likely exert independent effects on both the microbiome and immune compartments and can also impact their interaction. Understanding whether and how microbiome-targeted interventions might improve transplant outcomes will therefore require careful disentangling of these effects within each specific treatment context. ClinicalTrials.gov identifier: NCT03959241 .

Read the original source →

Related Stories

Health & Medicine

Homeostatic control of stem cell activity during intestinal regeneration.

Stem cells proliferate rapidly to maintain tissue turnover during regeneration, yet the mechanisms preventing hyperproliferation remain unclear. Here, we identified nuclear factor Y (NF-Y) as a transcriptional repressor that maintains intestinal stem cell (ISC) quiescence. NF-Y restricts ISC proliferation by occupying the promoters of epidermal growth factor receptor (EGFR) signaling components, including Egfr , Mkp3 , Raf , Ras , and pnt , through regulation dependent on the histone acetyltrans

Continue reading
Health & Medicine

Spatial transcriptomics reveals organizational properties of the mouse spinal cord and alterations in neuropathic pain.

The spinal cord integrates diverse somatosensory inputs and executes motor outputs through anatomically and functionally distinct circuits. Here, we employed spatially resolved single-cell transcriptomic profiling of the adult mouse spinal cord to gain insights into the organizational logic of the spinal cord. Our results reveal distinct spatial and laminar distributions of neuronal subtypes, including axial level and sex-specific differences. Many neuronal subtypes exhibit lamina-specific somat

Continue reading
Health & Medicine

Acute degradation of Pumilio proteins reveals a biphasic posttranscriptional regulatory hierarchy in embryonic stem cell fate decision.

Posttranscriptional regulation is critical for mammalian embryogenesis yet has been underexplored. We previously showed that RNA-binding Pumilio proteins (Pum1/2) are essential for early mouse embryogenesis and embryonic stem cell (ESC) functions. Here, using acute protein degradation systems combined with time-resolved RNA sequencing and enhanced crosslinking and immunoprecipitation, we delineate a two-phase regulatory hierarchy modulated by Pum1/2 in mouse ESCs. The first phase, occurring with

Continue reading
Health & Medicine

Elastic interactions of mechanically polarizable cells.

Cells mechanically interact through the deformations they generate in their surrounding extracellular matrix. We present an analytical theory of the elastic interactions between cells that actively adapt their forces in response to local deformations of their environment. Cells are represented as localized contractile force generators, modeled as polarizable point force dipoles, whose adaptive forces are determined self-consistently with those of surrounding cells. Analysis of the associated ela

Continue reading
Health & Medicine

ChREBP drives diabetic kidney disease, and its inhibition confers renal protection.

Chronic kidney disease (CKD) represents a major medical burden. Diabetic kidney disease (DKD) is a leading cause of CKD, but intracellular pathways that can be pharmacologically targeted are poorly defined. Using transcriptome screening of DKD model mice we found that a carbohydrate-responsive element-binding protein (ChREBP)-dependent transcriptional cascade is markedly up-regulated in diabetic kidneys. Genetic ablation of ChREBP in diabetic mice ameliorated DKD, establishing ChREBP as a potent

Continue reading